BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Feb. 2, 2004
View Archived Issues
Palatin Raises $22.7M For Drug Trials Via Stock, Warrants Sale
Read More
Inspire Will Conduct Additional Trial For More Diquafosol Data
Read More
Wall Street's Gilead Anxiety Unfounded, Analyst Believes
Read More
Correction
Read More
Other News To Note
Read More
Appointments And Advancements
Read More
Eyetech Stock Surges With Biotech's First IPO Of 2004
Earning the honor of first biotechnology company to conduct an IPO this year, Eyetech Pharmaceuticals Inc. raised $136.5 million and watched its stock skyrocket on Friday, trading up 54.3 percent from its opening price. (BioWorld Today)
Read More